文献速递头颈外科

8种吸烟指标在头颈部鳞状细胞癌生存建模中的表现

Performance of 8 Smoking Metrics for Modeling Survival in Head and Neck Squamous Cell Carcinoma.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2025-01-01

该回顾性多中心队列研究纳入6项临床流行病学研究中的8875例头颈部鳞状细胞癌患者,比较8种吸烟指标对总生存的建模表现。吸烟年限(aHR 1.11,95%CI 1.03-1.19)和对数吸烟年支数(aHR 1.11,95%CI 1.04-1.18)的aHR最高,且均与总生存呈统计学显著的线性关联;对数吸烟年支数的AIC线性值最低、样条曲线视觉最接近线性。

要点

  • 吸烟年限和对数吸烟年支数的aHR均为1.11,均与总生存呈统计学显著线性关联。
  • 对数吸烟年支数的AIC线性值最低、样条曲线视觉最接近线性。
  • 无论年龄、吸烟状态和癌症分期,吸烟年限和对数吸烟年支数建模总生存均优于包年。

核心结论

  • 在该队列研究中,吸烟年限和对数吸烟年支数最能模拟与头颈部鳞状细胞癌患者总生存的线性关系。
  • 两种指标在特定临床人口学亚组和解剖亚部位中均保持稳健表现。
  • 尽管多数头颈部鳞状细胞癌生存模型用吸烟状态或包年控制吸烟暴露,吸烟年限和对数吸烟年支数可能是更优的指标。

研究设计与样本

  • 回顾性多中心队列研究,纳入6项临床流行病学研究,其中5项属于VOYAGER联盟。
  • 纳入18岁及以上、病理确诊的头颈部鳞状细胞癌患者,共8875例(女性2114例,占24%;中位年龄61岁,IQR 54-69岁)。
  • 数据收集时间为2002年1月至2019年12月,数据分析时间为2022年1月至2024年11月。
  • 主要结局为总生存,比较8种吸烟指标(包括包年、吸烟年限和对数吸烟年支数)的建模表现。
  • 指标表现通过Cox比例风险模型的关联强度、基于线性趋势P值的线性、AIC(值越低模型拟合越好)和样条曲线视觉评估衡量。

主要发现

  • 8种吸烟指标中,吸烟年限的aHR为1.11(95%CI 1.03-1.19),对数吸烟年支数的aHR为1.11(95%CI 1.04-1.18),两者aHR最高且均与总生存呈统计学显著线性关联。
  • 对数吸烟年支数建模总生存时AIC线性值最低、样条曲线视觉最接近线性。
  • 无论年龄、吸烟状态和癌症分期,吸烟年限和对数吸烟年支数建模总生存均优于包年。
  • 吸烟年限和对数吸烟年支数在唇及口腔、喉(仅吸烟年限显著)和人乳头瘤病毒阴性口咽亚部位均表现良好。
  • 探索性分析中,建模非癌症生存时吸烟年限aHR最高(1.15,95%CI 1.02-1.29),对数吸烟年支数AIC线性值最低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Cigarette smoking is a strong risk factor for mortality in patients diagnosed with head and neck squamous cell carcinoma (HNSCC). However, little evidence supports which smoking metric best models the association between smoking and survival in HNSCC. OBJECTIVE: To determine which smoking metric best models a linear association between smoking exposure and overall survival (OS) in patients with HNSCC. DESIGN, SETTING, AND PARTICIPANTS: A retrospective multicenter cohort study of 6 clinical epidemiological studies was performed. Five were part of the Human Papillomavirus, Oral and Oropharyngeal Cancer Genomic Research (VOYAGER) consortium. Participants included patients 18 years and older with pathologically confirmed HNSCC. Data were collected from January 2002 to December 2019, and data were analyzed between January 2022 to November 2024. MAIN OUTCOMES AND MEASURES: The primary outcome was OS. The performance of 8 smoking metrics, including pack-years, duration, and log cig-years (calculated as log10[cigarettes smoked per day + 1] × number of years smoked) for modeling OS were compared. Metric performance was measured by the strength of association in Cox proportional hazard models, linearity based on P for linear trend, Akaike information criterion (AIC; lower value indicates better model fit), and visual assessment of spline curves. Secondary outcomes included modeling OS in clinicodemographic subgroups and HNSCC anatomic subsites. Exploratory outcomes included cancer-specific survival and noncancer survival. RESULTS: In total, 8875 patients with HNSCC (2114 [24%] female; median [IQR] age, 61 [54-69] years) were included. Of 8 smoking metrics evaluated, smoking duration (adjusted hazard ratio [aHR], 1.11 [95% CI, 1.03-1.19]) and log cig-years (aHR, 1.11 [95% CI, 1.04-1.18]) had the highest aHRs; both had a statistically significant linear association with OS. Log cig-years had the lowest AIC linear value and the most visually linear spline curve when modeling OS. Duration and log cig-years outperformed pack-years for modeling OS regardless of age, smoking status, and cancer stage. Both performed well in lip and oral cavity, laryngeal (only duration was significant), and human papillomavirus-negative oropharyngeal subsites. In an exploratory analysis, duration had the highest aHR (1.15 [95% CI, 1.02-1.29]), and log cig-years had the lowest AIC linear value when modeling noncancer survival. CONCLUSIONS AND RELEVANCE: In this cohort study, smoking duration and log cig-years best modeled a linear relationship with OS for patients with HNSCC. Both metrics maintained robust performance within specific clinicodemographic subgroups and anatomic subsites. Although most HNSCC survival models control for smoking exposure using smoking status or pack-years, duration and log cig-years may be superior metrics to account for the effects of smoking on survival.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Lam ACL, Hueniken K, Pienkowski M, et al. Performance of 8 Smoking Metrics for Modeling Survival in Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2025. PMID: 39976935. doi:10.1001/jamaoto.2024.5392

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。